• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于基因和细胞治疗的滚瓶中基于HIV的慢病毒载体的高滴度生产。

High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.

作者信息

Olgun Hazal Banu, Tasyurek Hale M, Sanlioglu Ahter Dilsad, Sanlioglu Salih

机构信息

Human Gene and Cell Therapy Center of Akdeniz University Hospitals, Antalya, Turkey.

出版信息

Methods Mol Biol. 2019;1879:323-345. doi: 10.1007/7651_2018_150.

DOI:10.1007/7651_2018_150
PMID:29797007
Abstract

Lentiviral vectors are becoming preferred vectors of choice for clinical gene therapy trials due to their safety, efficacy, and the long-term gene expression they provide. Although the efficacy of lentiviral vectors is mainly predetermined by the therapeutic genes they carry, they must be produced at high titers to exert therapeutic benefit for in vivo applications. Thus, there is need for practical, robust, and scalable viral vector production methods applicable to any laboratory setting. Here, we describe a practical lentiviral production technique in roller bottles yielding high-titer third-generation lentiviral vectors useful for in vivo gene transfer applications. CaPO-mediated transient transfection protocol involving the use of a transfer vector and three different packaging plasmids is employed to generate lentivectors in roller bottles. Following clearance of cellular debris via low-speed centrifugation and filtration, virus is concentrated by high-speed ultracentrifugation over sucrose cushion.

摘要

慢病毒载体因其安全性、有效性以及所提供的长期基因表达,正成为临床基因治疗试验中首选的载体。尽管慢病毒载体的有效性主要由其携带的治疗性基因预先决定,但为了在体内应用中发挥治疗作用,它们必须以高滴度生产。因此,需要适用于任何实验室环境的实用、稳健且可扩展的病毒载体生产方法。在此,我们描述了一种在滚瓶中生产慢病毒的实用技术,可产生用于体内基因转移应用的高滴度第三代慢病毒载体。采用涉及使用转移载体和三种不同包装质粒的磷酸钙介导的瞬时转染方案,在滚瓶中产生慢病毒载体。通过低速离心和过滤清除细胞碎片后,病毒通过在蔗糖垫层上进行高速超速离心进行浓缩。

相似文献

1
High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.用于基因和细胞治疗的滚瓶中基于HIV的慢病毒载体的高滴度生产。
Methods Mol Biol. 2019;1879:323-345. doi: 10.1007/7651_2018_150.
2
High-Grade Purification of Third-Generation HIV-Based Lentiviral Vectors by Anion Exchange Chromatography for Experimental Gene and Stem Cell Therapy Applications.通过阴离子交换色谱法对基于第三代HIV的慢病毒载体进行高级纯化,用于实验性基因和干细胞治疗应用。
Methods Mol Biol. 2019;1879:347-365. doi: 10.1007/7651_2018_154.
3
Production of lentiviral vectors for transducing cells from the central nervous system.用于转导中枢神经系统细胞的慢病毒载体的生产。
J Vis Exp. 2012 May 24(63):e4031. doi: 10.3791/4031.
4
Packaging HIV- or FIV-based lentivector expression constructs and transduction of VSV-G pseudotyped viral particles.包装基于HIV或FIV的慢病毒载体表达构建体并转导VSV-G假型化病毒颗粒。
J Vis Exp. 2012 Apr 8(62):e3171. doi: 10.3791/3171.
5
RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.RD114 包膜蛋白为假型慢病毒载体提供了一种有效且通用的方法。
Exp Biol Med (Maywood). 2010 Oct;235(10):1269-76. doi: 10.1258/ebm.2010.010053. Epub 2010 Sep 27.
6
Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.用于长期大规模生产高滴度基于HIV-1的慢病毒载体的包装细胞系的构建
J Gene Med. 2005 Jun;7(6):818-34. doi: 10.1002/jgm.726.
7
Optimized Transgene Delivery Using Third-Generation Lentiviruses.优化第三代慢病毒转染效率。
Curr Protoc Mol Biol. 2020 Dec;133(1):e125. doi: 10.1002/cpmb.125.
8
Improved third-generation lentiviral packaging with pLKO.1C vectors.第三代慢病毒包装载体 pLKO.1C 的改良。
Biotechniques. 2020 Jun;68(6):349-352. doi: 10.2144/btn-2019-0155. Epub 2020 Mar 6.
9
Factors influencing the titer and infectivity of lentiviral vectors.影响慢病毒载体滴度和感染性的因素。
Hum Gene Ther. 2004 Oct;15(10):976-88. doi: 10.1089/hum.2004.15.976.
10
Gene Transfer into Pluripotent Stem Cells via Lentiviral Transduction.通过慢病毒转导将基因导入多能干细胞
Methods Mol Biol. 2016;1341:67-85. doi: 10.1007/7651_2015_221.

引用本文的文献

1
Generation of a Beta-Cell Transplant Animal Model of Diabetes Using CRISPR Technology.利用 CRISPR 技术生成糖尿病胰岛细胞移植动物模型。
Adv Exp Med Biol. 2023;1409:145-159. doi: 10.1007/5584_2022_746.
2
Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes.慢病毒介导的胰岛β细胞特异性胰岛素基因治疗链脲佐菌素诱导的糖尿病。
Mol Ther. 2021 Jan 6;29(1):149-161. doi: 10.1016/j.ymthe.2020.10.025. Epub 2020 Oct 31.
3
Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation.
慢病毒基因治疗载体编码 VIP 抑制糖尿病相关炎症并增强胰岛 β 细胞增殖。
Gene Ther. 2021 Apr;28(3-4):130-141. doi: 10.1038/s41434-020-0183-3. Epub 2020 Jul 30.
4
Assessment and streamlined preparation of low-cytotoxicity lentiviral vectors for mobilized human hematopoietic stem cell transduction.评估和简化低细胞毒性慢病毒载体的制备,用于动员的人造血干细胞转导。
Exp Hematol. 2020 Jun;86:28-42.e3. doi: 10.1016/j.exphem.2020.05.009. Epub 2020 May 27.